EBITDA on steroids

The EBITDA addback is one of the most worrying aspects of loan documentation. Market professionals detail how prevalent and potentially damaging it has become.

ByAndy Thomson

25 June 2019•10 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Manager strategy Private debt

EBITDA on steroids

Aksia

Akzo Nobel N.V.

Cliffwater

Houlihan Lokey

HSBC Bank (UK) Pension Scheme

Local Pensions Partnership Investments (LPPI)

TorreyCove Capital Partners- Acquired

Related articles